Optison Perflutren Protein-Type A Microspheres: Package Insert and Label Information (Page 3 of 3)

16.2 Storage and Handling

Store OPTISON refrigerated between 2° to 8°C (36° to 46°F). Storage at room temperature (up to 25°C or 77°F) for up to 24 hours is permitted. Do not freeze.

17 PATIENT COUNSELING INFORMATION

Advise patients to inform their healthcare provider if they develop any symptoms of hypersensitivity after OPTISON administration including rash, wheezing, or shortness of breath.

Distributed by GE Healthcare Inc., Marlborough, MA 01752 U.S.A.
Manufactured by GE Healthcare AS, Oslo, Norway
OPTISON™ is a trademark of GE Healthcare or one of its subsidiaries
GE and the GE Monogram are trademarks of General Electric Company.
Product of Norwegian Origin.

© 2021 General Electric Company — All rights reserved.

PRINCIPAL DISPLAY PANEL — 3 mL Vial Carton Label

GE Healthcare
NDC 0407-2707-18
Rx ONLY

OPTISON™
(Perflutren Protein-Type A
Microspheres Injectable
Suspension, USP)
3 mL

2707-18
Contains
18 x 3 mL Vials

(01)20304072707183

EXP.: DD MMM YYYY
LOT: 12345678

1200602 USA

PRINCIPAL DISPLAY PANEL -- 3 mL Vial Carton Label
(click image for full-size original)
OPTISON PERFLUTREN PROTEIN-TYPE A MICROSPHERES
human albumin microspheres and perflutren injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0407-2707
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
HUMAN ALBUMIN MICROSPHERES (HUMAN ALBUMIN MICROSPHERES) HUMAN ALBUMIN MICROSPHERES 10 mg in 1 mL
PERFLUTREN (PERFLUTREN) PERFLUTREN 0.22 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
N-ACETYL-DL-TRYPTOPHAN 0.2 mg in 1 mL
CAPRYLIC ACID 0.12 mg in 1 mL
SODIUM CHLORIDE
Product Characteristics
Color white (Clear lower layer and white upper layer) Score
Shape Size
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0407-2707-03 5 VIAL, SINGLE-USE in 1 CARTON contains a VIAL, SINGLE-USE
1 3 mL in 1 VIAL, SINGLE-USE This package is contained within the CARTON (0407-2707-03)
2 NDC:0407-2707-18 18 VIAL, SINGLE-USE in 1 CARTON contains a VIAL, SINGLE-USE
2 3 mL in 1 VIAL, SINGLE-USE This package is contained within the CARTON (0407-2707-18)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA020899 01/02/2002
Labeler — GE Healthcare Inc. (053046579)
Establishment
Name Address ID/FEI Operations
GE Healthcare AS 515048908 manufacture (0407-2707)
Establishment
Name Address ID/FEI Operations
Octapharma Pharmazeutika Produktionsgesellschaft, m.b.H 301119178 manufacture (0407-2707)
Establishment
Name Address ID/FEI Operations
Octapharma AB 558833179 manufacture (0407-2707)

Revised: 12/2022 GE Healthcare Inc.

Page 3 of 3 1 2 3

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2023. All Rights Reserved.